TRAIL DR5 receptor mediates anoikis in human colorectal carcinoma cell lines through the extrinsic apoptotic pathway

被引：0
|
作者：
Laguinge, Luciana M. [1 ]
Samara, Raed [1 ]
Jessup, John M. [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
756
引用
收藏
页数：2
相关论文
共 50 条
  • [1] DR5 receptor mediates anoikis in human colorectal carcinoma cell lines
    Laguinge, Luciana M.
    Samara, Raed N.
    Wang, Wenge
    El-Deiry, Wafik S.
    Corner, Georgia
    Augenlicht, Leonard
    Mishra, Lopa
    Jessup, J. Miburn
    CANCER RESEARCH, 2008, 68 (03) : 909 - 917
  • [2] Both TRAIL receptor DR5 isoforms are required for the induction of cell death in human colon carcinoma
    Jani, Tanvi S.
    DeVecchio, Jennifer
    Peters, Kristi
    Houghton, Janet
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [3] Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with Trail-R2 (DR5) signaling
    Samara, Raed N.
    Laguinge, Luciana M.
    Jessup, J. Milburn
    CANCER RESEARCH, 2007, 67 (10) : 4774 - 4782
  • [4] Mutation of the DR5/TRAIL receptor 2 gene is infrequent in hepatocellular carcinoma
    Jeng, YM
    Hsu, HC
    CANCER LETTERS, 2002, 181 (02) : 205 - 208
  • [5] Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist
    Subbiah, Vivek
    Brown, Robert E.
    Buryanek, Jamie
    Trent, Jonathan
    Ashkenazi, Avi
    Herbst, Roy
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (11) : 2541 - 2546
  • [6] Signaling through the TRAIL receptor DR5/FADD pathway plays a role in the apoptosis associated with skeletal myoblast differentiation
    O'Flaherty, J.
    Mei, Y.
    Freer, M.
    Weyman, C. M.
    APOPTOSIS, 2006, 11 (12) : 2103 - 2113
  • [7] Targeting the extrinsic apoptotic pathway in endometrial carcinoma cell lines and tumor cell explants
    Matias-Guiu, X.
    Dolcet, X.
    Llobet, D.
    Poveda, A.
    Pallares, J.
    Eritia, N.
    Yeramian, A.
    Sorolla, A.
    Ortega, E.
    Llombart-Cussac, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Genomic organization and mutation analyses of the DR5/TRAIL receptor 2 gene in colorectal carcinomas
    Arai, T
    Akiyama, Y
    Okabe, S
    Saito, K
    Iwai, T
    Yuasa, Y
    CANCER LETTERS, 1998, 133 (02) : 197 - 204
  • [9] Signaling through the TRAIL receptor DR5/FADD pathway plays a role in the apoptosis associated with skeletal myoblast differentiation
    J. O’Flaherty
    Y. Mei
    M. Freer
    C. M. Weyman
    Apoptosis, 2006, 11 : 2103 - 2113
  • [10] Small-molecule activation of the TRAIL receptor DR5 in human cancer cells
    Wang G.
    Wang X.
    Yu H.
    Wei S.
    Williams N.
    Holmes D.L.
    Halfmann R.
    Naidoo J.
    Wang L.
    Li L.
    Chen S.
    Harran P.
    Lei X.
    Wang X.
    Nature Chemical Biology, 2013, 9 (2) : 84 - 89
12345